Atlas Trials

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Clinical trial NCT07049575 · RECRUITING

Trial details

NCT number
NCT07049575
Sponsor
Incyte Corporation
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2025-11-03
Primary completion
2026-12-09
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.